Abdominal aortic dissection during sorafenib therapy for hepatocellular carcinoma

被引：6
|
作者：
Xu, Lin [1 ]
Wang, Boqing [1 ]
Ding, Wei [1 ]
机构：
[1] Xinjiang Med Univ, Affiliated Tumor Hosp, Dept Hepatopancreatobiliary Surg, Urumqi 830000, Peoples R China
来源：
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY | 2017年 / 41卷 / 02期
关键词：
D O I：
10.1016/j.clinre.2016.12.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E24 / E25
页数：2
相关论文
共 50 条
  • [31] Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib
    Yau, Thomas
    Pang, Roberta
    Chan, Pierre
    Poon, Ronnie T.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (13) : 2187 - 2198
  • [32] Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond
    Gadaleta-Caldarola, Gennaro
    Divella, Rosa
    Mazzocca, Antonio
    Infusino, Stefania
    Ferraro, Emanuela
    Filippelli, Gianfranco
    Daniele, Antonella
    Sabba, Carlo
    Abbate, Ines
    Brandi, Mario
    FUTURE ONCOLOGY, 2015, 11 (16) : 2263 - 2266
  • [33] Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy
    Azmi, Ahmad Najib
    Chan, Wah-Kheong
    Goh, Khean-Lee
    JOURNAL OF DIGESTIVE DISEASES, 2015, 16 (09) : 537 - 540
  • [34] Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma
    Corominas, Josep
    Sapena, Victor
    Sanduzzi-Zamparelli, Marco
    Millan, Cristina
    Samper, Esther
    Llarch, Neus
    Iserte, Gemma
    Torres, Ferran
    Da Fonseca, Leonardo G.
    Munoz-Martinez, Sergio
    Forner, Alejandro
    Bruix, Jordi
    Boix, Loreto
    Reig, Maria
    CANCERS, 2021, 13 (03) : 1 - 20
  • [35] Sorafenib Therapy in Patients with Hepatocellular Carcinoma Before Liver Transplantation
    Rowe, Ian A.
    HEPATOLOGY, 2010, 52 (03) : 1171 - 1172
  • [36] Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond
    Raoul, Jean-Luc
    Kudo, Masatoshi
    Finn, Richard S.
    Edeline, Julien
    Reig, Maria
    Galle, Peter R.
    CANCER TREATMENT REVIEWS, 2018, 68 : 16 - 24
  • [37] National data on sorafenib therapy adherence for veterans with hepatocellular carcinoma
    Malhotra, Sheetal
    Wu, David Ping-Hsin
    Park, Yeun-Hee Anna
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [38] Sorafenib in advanced hepatocellular carcinoma
    Sauerbruch, T.
    Gonzalez-Carmona, A. M.
    Nitschmann, S.
    INTERNIST, 2009, 50 (11): : 1290 - 1292
  • [39] Sorafenib for the treatment of hepatocellular carcinoma
    Woerns, Marcus Alexander
    Galle, Peter Robert
    HEPATIC ONCOLOGY, 2014, 1 (02) : 189 - 204
  • [40] Sorafenib in advanced hepatocellular carcinoma
    Llovet, Josep M.
    Ricci, Sergio
    Mazzaferro, Vincenzo
    Hilgard, Philip
    Gane, Edward
    Blanc, Jean-Frederic
    Cosme de Oliveira, Andre
    Santoro, Armando
    Raoul, Jean-Luc
    Forner, Alejandro
    Schwartz, Myron
    Porta, Camillo
    Zeuzem, Stefan
    Bolondi, Luigi
    Greten, Tim F.
    Galle, Peter R.
    Seitz, Jean-Francois
    Borbath, Ivan
    Haussinger, Dieter
    Giannaris, Tom
    Shan, Minghua
    Moscovici, Marius
    Voliotis, Dimitris
    Bruix, Jordi
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04): : 378 - 390
12345